Elsevier

International Immunopharmacology

Volume 52, November 2017, Pages 127-135
International Immunopharmacology

LOX-1 is involved in IL-1β production and extracellular matrix breakdown in dental peri-implantitis

https://doi.org/10.1016/j.intimp.2017.09.003Get rights and content

Highlights

  • LOX-1, IL-1β, MMP2 and MMP9 are involved in human dental peri-implantitis.

  • LOX-1 reduces P. gingivalis induced IL-1β production in macrophages.

  • JNK was responsible for LOX-1 induced IL-1β production upon P. gingivalis infection.

  • P. gingivalis induced MMP2 and MMP9 production in macrophages is dependent on LOX-1.

Abstract

Purpose

To explore whether lectin-type oxidized LDL receptor 1 (LOX-1), interleukin 1 beta (IL-1β), matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MMP9) are involved in the nosogenesis of human dental peri-implantitis and determine the role of LOX-1 in IL-1β, MMP2 and MMP9 production in response to Porphyromonas gingivalis.

Methods

Peri-implant crevicular fluid (PICF) was collected from ten patients with healthy implants and ten patients with peri-implantitis. The LOX-1 protein in PICF was detected by Western-blot, and the expression of LOX-1 in superficial gingiva of peri-implantitis patients was detected by immunofluorescence staining. The IL-1β, MMP2 and MMP9 proteins in PICF were detected by enzyme-linked immunosorbent assay (ELISA). THP-1 macrophages were pretreated with neutralizing antibody (LOX-1) and inhibitors (LOX-1 and c-Jun N-terminal kinase, JNK) to evaluate the role of LOX-1 and JNK in IL-1β production, as well as the role of LOX-1 in MMP2 and MMP9 production in response to P. gingivalis by quantitative polymerase chain reaction (RT-PCR) and Western-blot.

Results

LOX-1, IL-1β, MMP2 and MMP9 increased in PICF of peri-implantitis patients and in THP-1 macrophages on P. gingivalis stimulation. IL-1β, MMP2 and MMP9 production in response to P. gingivalis in THP-1 macrophages was dependent on LOX-1. JNK was responsible for LOX-1 induced IL-1β production as a result of P. gingivalis infection.

Conclusion

LOX-1 is involved in IL-1β production and extracellular matrix breakdown is a novel inflammatory pathway trigger and potential drug target in human dental peri-implantitis.

Introduction

A dental implant is one of the most frequently used treatments for tooth replacement in patients [1]. Dental peri-implantitis, an oral inflammatory disease leading to supporting tissues loss, affects approximately 30% of patients [1], [2], [3], [4]. There are various treatment options for peri-implantitis [5], [6], [7], however, there does not appear to be one superior treatment approach proved to be highly effective against peri-implantitis thus far.

Tissues surrounding dental implants and teeth develop an inflammatory reaction in response to microbial infection, including P. gingivalis [8], [9], [10], Prevotella intermedia [11], [12], and Aggregatibacter actinomycetemcomitans [13], [14] infection. The human immune system responds to the bacterial infection by the recruitment of neutrophils, macrophages, T cells, and B cells into the lesion [15], [16], [17], [18]. Compared with periodontitis, peri-implantitis exhibits a more extensive inflammatory infiltrate of innate immunity, severe tissue destruction and faster progression [19], [20]. There have been multiple studies regarding the immunological pathogenesis of periodontal diseases, although the effects of innate immune responses to peri-implantitis have not been thoroughly evaluated [21].

Pattern recognition receptors (PRRs) play a vital role in innate immunity. Pathogen-associated molecular patterns (PAMPs) from microbial pathogens and damage-associated molecular patterns (DAMPs) from released cell components during cell damage or death have been identified by PRRs in innate immunity [22], [23]. Lectin-type oxidized LDL receptor 1 (LOX-1) (also known as oxidized low-density lipoprotein receptor 1, oxLDL receptor 1) is a pattern recognition receptor of the C-type lectin superfamily. In addition to being an oxLDL receptor, LOX-1 is a multi-ligand receptor which binds to activated platelets, apoptotic cells, C-reactive protein, and bacteria [24], [25], [26]. LOX-1 is also involved in P. gingivalis-induced atherosclerosis [27], [28], [29]. However, no previous studies have explored the role of LOX-1 in peri-implantitis.

The present report demonstrated that LOX-1, interleukin 1 beta (IL-1β), matrix metalloproteinase 2 (MMP2) and matrix metalloproteinase 9 (MMP9) were increased in peri-implantitis patients and in human THP-1 macrophages stimulated with P. gingivalis. The LOX-1 induced IL-1β production upon P. gingivalis infection was JNK dependent. Furthermore, LOX-1 also regulated MMP2 and MMP9 production induced by P. gingivalis. These results show that LOX-1 is essential for IL-1β production and extracellular matrix breakdown in peri-implantitis.

Section snippets

Peri-implant crevicular fluid (PICF) collection

This study was approved by the ethics committee of the Affiliated Hospital of Qingdao University and conducted in accordance with the Helsinki Declaration. Each patient provided informed consent.

The study population consisted of twenty patients (10 healthy implant patients and 10 peri-implantitis patients, with each patient having at least two dental implants).Two dental implants from each patient were evaluated in this study. All implants had been used for no less than two years.

LOX-1, IL-1β, MMP2 and MMP9 increased in peri-implantitis patients

LOX-1 production in peri-implantitiswas investigated by Western-blot and immunofluorescence staining. The western blot results indicated that protein levels of LOX-1 were significantly higher (P < 0.01) in PICF of peri-implantitis patients compared to healthy implants (Fig. 1A). LOX-1 was located mainly in the cell membrane of the superficial gingiva of peri-implantitis patients (Fig. 1B). In addition, the protein levels of IL-1β (Fig. 1C), MMP2 (Fig. 1D) and MMP9 (Fig. 1E) were elevated in PICF

Discussion

Peri-implantitis is an increasing problem associated with dental implants [38], [39]. Recently, the research attention of peri-implantitis has shifted from the microbiology and etiology to the host-response and inflammatory mediators involved. The initial host-response of infection is mediated by PRRs, which include C-type lectin receptors, Toll-like receptors, RIG-I-like receptors and NOD-like receptors [40]. To eradicate pathogens and infected cells, the expression of inflammatory mediators

References (58)

  • T. Sorsa et al.

    Collagenase-2 (MMP-8) as a point-of-care biomarker in periodontitis and cardiovascular diseases. Therapeutic response to non-antimicrobial properties of tetracyclines

    Pharmacol. Res.

    (2011)
  • B. Schminke et al.

    The pathology of bone tissue during peri-implantitis

    J. Dent. Res.

    (2015)
  • M. Roccuzzo et al.

    Surgical treatment of peri-implantitis intrabony lesions by means of deproteinized bovine bone mineral with 10% collagen: 7-year-results

    Clin. Oral Implants Res.

    (2017)
  • S.J. Froum et al.

    Successful surgical protocols in the treatment of Peri-Implantitis: a narrative review of the literature

    Implant. Dent.

    (2016)
  • S. Renvert et al.

    Non-surgical treatment of peri-implant mucositis and peri-implantitis: a literature review

    J. Clin. Periodontol.

    (2008)
  • S. Renvert et al.

    Treatment modalities for peri-implant mucositis and peri-implantitis

    Am. J. Dent.

    (2013)
  • F. Suárez-López Del Amo et al.

    Non-surgical therapy for Peri-implant diseases: a systematic review

    J. Oral Maxillofac. Res.

    (2016)
  • C.F. Ferreira et al.

    Efficiency of nanotube surface-treated dental implants loaded with doxycycline on growth reduction of Porphyromonas gingivalis

    Int. J. Oral Maxillofac. Implants

    (2017)
  • M.A. Stokman et al.

    Bacterial colonization of the peri-implant sulcus in dentate patients: a prospective observational study

    Clin Oral Investig

    (2017)
  • L. Montebugnoli et al.

    Peri-implant response and microflora in organ transplant patients 1 year after prosthetic loading: a prospective controlled study

    Clin. Implant. Dent. Relat. Res.

    (2015)
  • L.F. Zhuang et al.

    Periodontal and peri-implant microbiota in patients with healthy and inflamed periodontal and peri-implant tissues

    Clin. Oral Implants Res.

    (2016)
  • Z. Kadkhoda et al.

    Antimicrobial effect of chlorhexidine on Aggregatibacter actinomycetemcomitans biofilms associated with peri-implantitis

    J. Dent. Res. Dent. Clin. Dent. Prospects

    (2016)
  • P.M. Jervøe-Storm et al.

    Internal bacterial colonization of implants: association with peri-implant bone loss

    Clin. Oral Implants Res.

    (2015)
  • L. Canullo et al.

    Soft tissue response to titanium abutments with different surface treatment: preliminary histologic report of a randomized controlled trial

    Biomed. Res. Int.

    (2016)
  • A. Insua et al.

    Basis of bone metabolism around dental implants during osseointegration and peri-implant bone loss

    J. Biomed. Mater. Res. A

    (2017)
  • T. Fretwurst et al.

    Metal elements in tissue with dental peri-implantitis: a pilot study

    Clin. Oral Implants Res.

    (2016)
  • N.A. Valente et al.

    Peri-implant disease: what we know and what we need to know

    J. Periodontal Implant Sci.

    (2016)
  • V. Sousa et al.

    Peri-implant and periodontal microbiome diversity in aggressive periodontitis patients: a pilot study

    Clin. Oral Implants Res.

    (2017)
  • T. Koutouzis et al.

    Innate immune receptor expression in peri-implant tissues of patients with different susceptibility to periodontal diseases

    J. Periodontol.

    (2013)
  • Cited by (17)

    • Vascular Biology of Arterial Aneurysms

      2023, Annals of Vascular Surgery
    • Yeast microcapsule-mediated oral delivery of IL-1β shRNA for post-traumatic osteoarthritis therapy

      2021, Molecular Therapy Nucleic Acids
      Citation Excerpt :

      IL-1β is one of the key genes involved in the pathogenesis of PTOA.7 It can promote the production of MMPs and enhance collagen and proteoglycan breakdown in cartilage.8,9 Previous study showed that viral-mediated IL-1R antagonist cDNA achieved disease-modifying effects via intra-articular administration.34,35

    • LOX-1 is involved in TLR2 induced RANKL regulation in peri-implantitis

      2019, International Immunopharmacology
      Citation Excerpt :

      Mai Nakayachi et al. [41] found that the expression of RANKL, IL-1β and prostaglandin E2 evoked by the inflammation were reduced in LOX-1 deficiency mice. Our previous study found that LOX-1 involves in IL-1β production and extracellular matrix breakdown in peri-implantitis [24]. In present study, our data demonstrated that down-regulation of TLR2 or LOX-1 reduced RANKL expression in P. gingivalis stimulated THP-1 macrophages.

    • Peri-implantitis Diagnosis and Prognosis Using Biomarkers: A Systematic Literature Review

      2023, International Journal of Oral and Maxillofacial Implants
    View all citing articles on Scopus

    Fundings: This study was supported by the National Natural Science Foundation of China (81300730, 81500882) and Applied Basic Research Project of Qingdao (16-5-1-65-jch). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

    View full text